{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:54:57Z","timestamp":1784872497902,"version":"3.55.0"},"reference-count":46,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1600,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1365-2036.2011.04659.x","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T08:53:44Z","timestamp":1302857624000},"page":"1361-1369","source":"Crossref","is-referenced-by-count":95,"title":["Development of type I gastric carcinoid in patients with chronic atrophic gastritis"],"prefix":"10.1111","volume":"33","author":[{"given":"L.","family":"Vannella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sbrozzi-Vanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Pilozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. D.","family":"Corleto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Delle Fave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Annibale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,4,15]]},"reference":[{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1365-2036.2006.03130.x","article-title":"Review article: pathogenesis and management of gastric carcinoid tumours","volume":"24","author":"Burkitt","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s002689900026","article-title":"Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior","volume":"20","author":"Rindi","year":"1996","journal-title":"World J Surg"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/0016-5085(93)90266-F","article-title":"Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study","volume":"104","author":"Rindi","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.cco.0000147899.04701.c6","article-title":"Gastric carcinoid","volume":"17","author":"Mulkeen","year":"2005","journal-title":"Curr Opin Oncol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB5|cit5","first-page":"273","article-title":"Pathogenesis of ECL cell tumors in humans","volume":"71","author":"Bordi","year":"1998","journal-title":"Yale J Biol Med"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.physiol.63.1.119","article-title":"The gastrins:their production and biological activities","volume":"63","author":"Dockray","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000199609","article-title":"The achlorhydria-carcinoid sequence: role of gastrin","volume":"39","author":"Creutzfeldt","year":"1988","journal-title":"Digestion"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2036.2011.04659.x-BIB8|cit8","first-page":"S8","article-title":"Hypergastrinemia and gastric enterochromaffin-like cells","volume":"19","author":"Bordi","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1572-0241.2003.04027.x","article-title":"A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?","volume":"99","author":"Modlin","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1038\/ajg.2010.341","article-title":"Carcinoid tumors of the gastrointestinal tract: trends in Incidence in England Since 1971","volume":"105","author":"Ellis","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB11|cit11","first-page":"72","article-title":"Gastric carcinoids with minimal or no macroscopic lesion in patients with pernicious anemia","volume":"32","author":"Lehtola","year":"1985","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0960-7404(03)00034-3","article-title":"Carcinoid tumors of the stomach","volume":"12","author":"Modlin","year":"2003","journal-title":"Surg Oncol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/00042737-200112000-00008","article-title":"Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid","volume":"13","author":"Annibale","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/00365529850166266","article-title":"The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study","volume":"33","author":"Kokkola","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-2007-1018130","article-title":"Gastroscopic screening for gastric carcinoids and carcinoma in pernicious anemia","volume":"20","author":"Sj\u00f6blom","year":"1988","journal-title":"Endoscopy"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1523-5378.1997.tb00060.x","article-title":"Atrophic body gastritis: distinct features associated with H. pylori infection","volume":"2","author":"Annibale","year":"1997","journal-title":"Helicobacter"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2036.2002.01213.x","article-title":"Role of H. pylori serology in atrophic body gastritis after eradication treatment","volume":"16","author":"Lahner","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000199786","article-title":"Histopathological classification of nonantral gastric endocrine growths in man","volume":"41","author":"Solcia","year":"1988","journal-title":"Digestion"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1210\/jc.2007-2279","article-title":"A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors","volume":"93","author":"Berna","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1210\/jc.86.5.2236","article-title":"The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes","volume":"86","author":"Bordi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1038\/ajg.2009.231","article-title":"Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency","volume":"104","author":"Lahner","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjmed.2007.09.025","article-title":"Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis","volume":"121","author":"Lahner","year":"2008","journal-title":"Am J Med"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1067\/mge.2001.112189","article-title":"First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done?","volume":"53","author":"Lahner","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB25|cit25","first-page":"633","article-title":"A 40-year analysis of 265 gastric carcinoids","volume":"92","author":"Modlin","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1007\/s00464-005-0232-4","article-title":"Gastric carcinoids: a temporal increase with proton pump introduction","volume":"19","author":"Hodgson","year":"2005","journal-title":"Surg Endosc"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.gie.2006.02.004","article-title":"Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract","volume":"63","author":"Hirota","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB28|cit28","first-page":"766","article-title":"High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia: a prospective screening study","volume":"94","author":"Marignani","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/gut.24.12.1141","article-title":"Gastroscopic screening in 80 patients with pernicious anaemia","volume":"24","author":"Stockbr\u00fcgger","year":"1983","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00000478-198706000-00004","article-title":"Gastric carcinoid associated with the syndrome of hypergastrinemic atrophic gastritis. A prospective analysis of 11 cases","volume":"11","author":"Borch","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1245\/s10434-010-1006-3","article-title":"Chromogranin A - biological function and clinical utility in neuro endocrine tumor disease","volume":"17","author":"Modlin","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/00365529709000194","article-title":"Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis","volume":"32","author":"Borch","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/eje.1.01862","article-title":"Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids","volume":"152","author":"Peracchi","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrgastro.2009.70","article-title":"Management of gastric polyps: a pathology-based guide for gastroenterologists","volume":"6","author":"Carmack","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1136\/gut.2009.182089","article-title":"British Society of Gastroenterology. The management of gastric polyps","volume":"59","author":"Goddard","year":"2010","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00428-005-0068-2","article-title":"Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa?","volume":"448","author":"Dirschmid","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2036.2005.02399.x","article-title":"Occurrence and risk factors for benign epithelial gastric polyps in atrophic body gastritis on diagnosis and follow-up","volume":"21","author":"Di Giulio","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jso.20468","article-title":"Presentation, treatment, and outcome of type 1 gastric carcinoid tumors","volume":"93","author":"Dakin","year":"2006","journal-title":"J Surg Oncol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/MEG.0b013e328220eae0","article-title":"Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue","volume":"19","author":"Manfredi","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/EJE-08-0420","article-title":"Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours","volume":"159","author":"Grozinsky-Glasberg","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s10120-004-0303-6","article-title":"Long-term follow up of patients with multiple gastric carcinoids associated with type A gastritis","volume":"8","author":"Hosokawa","year":"2005","journal-title":"Gastric Cancer"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.dld.2007.01.018","article-title":"Long-term endoscopic and clinical follow-up of untreated type 1 gastric neuroendocrine tumours","volume":"39","author":"Ravizza","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/gut.43.2.223","article-title":"Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids","volume":"24","author":"Granberg","year":"1998","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.sla.0000167862.52309.7d","article-title":"Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type","volume":"242","author":"Borch","year":"2005","journal-title":"Ann Surg"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000098007","article-title":"Frascati Consensus Conference; European neuroendocrine Tumor Society. Well-differentiated gastric tumors\/carcinomas","volume":"84","author":"Ruszniewski","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1111\/j.1365-2036.2011.04659.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000225952","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: follow-up and documentation","volume":"90","author":"Arnold","year":"2009","journal-title":"Neuroendoscrinology"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2011.04659.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2036.2011.04659.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T21:01:06Z","timestamp":1625432466000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2011.04659.x"}},"subtitle":["Type I gastric carcinoids in atrophic gastritis"],"short-title":[],"issued":{"date-parts":[[2011,4,15]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04659.x","relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,15]]}}}